Why is Krebs Biochem falling/rising?

As of 17-Sep, Krebs Biochemicals & Industries Ltd is experiencing a price increase, currently at Rs 81.00, reflecting a rise of Rs 2.25 or 2.86%. The stock has shown strong performance recently, gaining 8% over the last two days and outperforming its sector by 2.82% today. It reached an intraday high of Rs 81.49, although it also touched a low of Rs 76. The stock has been trading above its 5-day, 20-day, 50-day, and 100-day moving averages, indicating a positive short-term trend, despite being below the 200-day moving average. Additionally, there has been a significant increase in investor participation, with delivery volume rising by over 1284% compared to the 5-day average, suggesting heightened interest in the stock.
In the broader market context, Krebs Biochem's short-term performance has outpaced the Sensex, which gained 1.56% over the past week compared to the stock's 6.79% increase. However, the stock's year-to-date performance remains negative at -12.43%, contrasting with the Sensex's positive return of 5.83%. This indicates that while the stock is currently on an upward trajectory, it has struggled over a longer time frame. The significant rise in trading volume and recent price movements suggest a potential recovery, but the overall trend over the past year and three years remains concerning, with the stock down 14.74% and 34.28%, respectively, compared to the benchmark.